Hermes
ID: 353643Type: Posted
Overview

Buyer

DARPA - Biological Technologies Office (DOD-DARPA-BTO)

Eligible Applicants

Others

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Procurement Contract

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353643

Additional Information

https://sam.gov/opp/68fe51044e5f4c588cb1aa0faae9cc12/view
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Apr 19, 2024, 12:00 AM UTC
  4. 4
    Due Jun 11, 2024, 12:00 AM UTC
Description

The Defense Advanced Research Projects Agency (DARPA) is inviting innovative proposals for the Hermes program, which focuses on developing systemic drug delivery platforms for medical countermeasures (MCMs). The program seeks transformative approaches that ensure effective biodistribution, high endosomal escape efficiency, and low toxicity in the proposed delivery systems. Successful applicants will need to provide a comprehensive proposal detailing their delivery platform, including a screening pipeline, monitoring systems for biodistribution and expression, immunogenicity/toxicity assessment methods, and justification for the chosen therapeutic cargo. Proposals are due by June 11, 2024, at 4:00 PM ET, and interested parties can reach out to Dr. Shannon Greene at HermesBAA@darpa.mil for further inquiries. More information can be found on the SAM.gov Contract Opportunities website.

Point(s) of Contact
HermesBAA@darpa.mil
Files
Title
Posted
HR001124S0025-Amendment-01.pdf
Aug 24, 2024, 2:22 AM UTC
Amendment 1 to HR001124S0025, pertaining to the Hermes Broad Agency Announcement, primarily aims to extend the deadline for full proposal submissions. The revised proposal due date is now set for June 11, 2024, at 4:00 PM ET, coinciding with the BAA closing date. This extension provides potential applicants additional time to prepare their proposals in response to the announcement. Such amendments are common in government RFPs and grants, allowing for increased participation and submission quality by accommodating the needs of applicants. This change underlines the government's commitment to an inclusive proposal process while maintaining necessary timelines for project initiation.
Similar Opportunities
DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
Dept. of the Army -- USAMRAA
The Department of the Army, through the U.S. Army Medical Research and Development Command (USAMRDC), has announced the FY23-FY27 Broad Agency Announcement (BAA) for Extramural Medical Research, which is open for submissions from October 1, 2022, to September 30, 2027. This opportunity invites innovative research proposals that address critical military medical challenges, particularly in the areas of Military Infectious Diseases, Combat Casualty Care, and Military Operational Medicine, with a focus on enhancing medical practices for both military personnel and civilians. The BAA emphasizes the importance of collaboration with Department of Defense and Department of Veterans Affairs resources and requires adherence to strict submission guidelines via Grants.gov and the electronic Biomedical Research Application Portal (eBRAP). Interested applicants can submit pre-proposals at any time during the five-year period, with full proposals invited based on initial submissions, and should direct inquiries to the CDMRP Help Desk at help@eBRAP.org.
TTO Office Wide (OW) BAA
DARPA - Tactical Technology Office
The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals through its Broad Agency Announcement (BAA) HR001124S0023, aimed at enhancing national security via the Tactical Technology Office (TTO). Proposals should focus on key areas such as Platform Innovation, Missionized Autonomy, Managing Complexity, Freedom’s Forge 2.0, and Disruptive Emergent Technology, with the goal of demonstrating revolutionary platforms and systems that can be rapidly built and adapted. This initiative is critical for fostering technologies that can disrupt traditional defense paradigms and improve operational efficiency. Interested parties must submit executive summaries by April 19, 2025, with full proposals due by June 20, 2025; for further details, contact the BAA Coordinator at HR001124S0023@darpa.mil.
Defense Sciences Office (DSO) Office-wide BAA
DARPA - Defense Sciences Office
The Defense Advanced Research Projects Agency (DARPA) is inviting proposals through its Defense Sciences Office (DSO) Office-wide Broad Agency Announcement (BAA) HR001124S0039, aimed at fostering innovative scientific research for national security applications. The BAA specifically seeks revolutionary advancements in six key technical areas: Novel Materials & Structures, Sensing & Measurement, Computation & Processing, Enabling Operations, Collective Intelligence, and Emerging Threats, while excluding research focused on incremental improvements. This opportunity is crucial for advancing cutting-edge technologies that enhance defense capabilities, with proposals accepted on a rolling basis until September 26, 2025. Interested parties can contact the BAA Coordinator at HR001124S0039@darpa.mil for further details, and are encouraged to submit preliminary executive summaries for feedback prior to full proposal submissions.
Airman Readiness Medical Research (ARMR) Hybrid BAA
Air Force -- Research Lab
The Air Force Research Laboratory (AFRL) is soliciting proposals for the Airman Readiness Medical Research (ARMR) program through a Hybrid Broad Agency Announcement (BAA) designated FA8650-20-S-6008. The primary objectives of this initiative are to conduct medical research aimed at optimizing the health and performance of Airmen, focusing on ensuring medical availability and understanding the effects of various operational environments on Airman well-being. This program is critical for enhancing the operational readiness of military personnel, particularly in high-demand mission scenarios, with key research areas including aeromedical evacuation, cognitive performance, and exposure health. The total funding available for this program is estimated at $480 million, with individual awards ranging from $50,000 to $49 million. Interested parties are encouraged to submit white papers by May 1, 2025, and can direct inquiries to Amber A. Taylor at amber.taylor.9@us.af.mil.
Microsystems Technology Office (MTO) Office-wide
DARPA - Microsystems Technology Office
The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative research proposals through the Microsystems Technology Office (MTO) under Broad Agency Announcement HR001124S0028. This opportunity aims to foster high-risk, high-reward technologies that are not currently being addressed by existing MTO programs, with a focus on emerging circuit technologies such as quantum, photonic, and bio/organic circuits, as well as the development of a sustainable microsystems manufacturing ecosystem. The BAA encourages participation from all responsible sources, including minority and disadvantaged businesses, and emphasizes the importance of addressing national security implications in proposals. Interested parties should submit abstracts on a rolling basis until March 9, 2025, with full proposals due by May 9, 2025. For further information, contact Dr. Whitney Mason at HR001124S0028@darpa.mil, and additional details can be found at the SAM.gov Contract Opportunities page.
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has announced a Broad Agency Announcement (BAA) for Extramural Biomedical and Human Performance Research and Development. This opportunity invites unrestricted applicants to submit proposals aimed at advancing biomedical research and development, with a focus on enhancing human performance. The program is critical for fostering innovation in science and technology, particularly in areas that support the Department of Defense's mission. The estimated total program funding is $10 million, with individual awards ranging from $750,000 to $50 million, and proposals are due by July 31, 2028. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
Fundamental Research to Counter Weapons of Mass Destruction
Defense Threat Reduction Agency
The Defense Threat Reduction Agency (DTRA) has announced a Broad Agency Announcement (BAA) for fundamental research aimed at countering Weapons of Mass Destruction (WMD), with funding available from October 1, 2024, to September 30, 2034. This opportunity invites proposals from accredited colleges, universities, and research entities to contribute to DTRA's mission of reducing WMD threats, emphasizing collaboration in areas such as chemical and biological defense. The funding will primarily be awarded as grants, with amounts ranging from $25,000 to $1 million annually, and proposals will undergo a two-phase evaluation process assessing scientific merit and mission relevance. Interested applicants should submit pre-application white papers and can direct inquiries to the BAA Administrative Mailbox at dtra.belvoir.rd.mbx.rd-cb-frbaa25-34-a@mail.mil before the closing date of September 30, 2034.
Biological Threat Reduction with Global Partners Broad Agency Announcement (BAA)
Defense Threat Reduction Agency
The Defense Threat Reduction Agency (DTRA) has announced a Broad Agency Announcement (BAA) titled "Biological Threat Reduction with Global Partners," aimed at enhancing global health security against biological threats. This initiative invites submissions of Abstracts, White Papers, and Full Proposals from accredited universities, industry, and non-profit organizations to strengthen the capabilities of partner nations in preventing, detecting, and responding to biological threats, including diseases. The BAA emphasizes collaborative scientific studies to improve disease diagnostics, evaluate training programs, and establish biosecurity protocols, ultimately contributing to global biological threat reduction efforts. Interested applicants can find more information and submit proposals through the Grant Opportunities website, with the submission period running from April 29, 2024, to April 28, 2029. For inquiries, contact the CTR BAA Team at dtra.belvoir.ct.mbx.ctr-baa@mail.mil.
Information Innovation Office (I2O) Office-Wide
DARPA - Information Innovation Office
The Defense Advanced Research Projects Agency (DARPA) is inviting proposals for the Information Innovation Office (I2O) Office-Wide Broad Agency Announcement (BAA) HR001125S0002, aimed at fostering revolutionary research in information and computational technologies to enhance national security. Proposals should focus on innovative ideas not currently addressed by existing I2O programs, particularly in areas such as artificial intelligence, resilient systems, and cyber operations, while avoiding duplication of previous efforts. This opportunity is critical for advancing defense capabilities through pioneering research and is open to all responsible sources capable of meeting the government's needs. Proposals will be accepted until October 29, 2025, with interested parties encouraged to submit abstracts for preliminary feedback. For further details, contact the BAA Coordinator at HR001125S0002@darpa.mil or visit the SAM.gov Contract Opportunities page.
DOD Amyotrophic Lateral Sclerosis, Therapeutic Idea Award
Dept. of the Army -- USAMRAA
The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Therapeutic Idea Award (TIA) under the fiscal year 2025 Amyotrophic Lateral Sclerosis Research Program (ALSRP). This grant aims to support innovative, high-risk research proposals focused on drug or therapy development for Amyotrophic Lateral Sclerosis (ALS), with an emphasis on generating preliminary data for future therapeutic investigations. The program has a total funding amount of approximately $10.8 million, with individual awards capped at $600,000 and a performance period not exceeding two years. Interested applicants must submit pre-applications by June 6, 2025, and full applications by August 27, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.